FDA drops blood pressure device enforcement against Whoop on June 25, 2026 Advice Blood Pressure Insights BPI gene Cautionary Warning enforcement enforcement action Health Letter [Publication Type] Protein Domain United States Food and Drug Administration Whooping respiration +
Friday Five: Novo Nordisk Sues Hims & Hers Over Compounded GLP-1 Drugs Amid FDA Crackdown on February 13, 2026 enforcement Glucagon-Like Peptide 1 Hims Novo Nordisk Ozempic patent infringement semaglutide United States Food and Drug Administration Wegovy +
Friday Five: Novo Nordisk Sues Hims & Hers Over Compounded GLP-1 Drugs Amid FDA Crackdown on February 13, 2026 enforcement Glucagon-Like Peptide 1 Hims Novo Nordisk Ozempic patent infringement semaglutide United States Food and Drug Administration Wegovy +
Legal Pressure Escalates as FDA Intensifies Crackdown on Direct-to-Consumer Pharma Advertising on October 03, 2025 Direct-to-Consumer Advertising enforcement Legal Challenges pharmaceutical advertising crackdown prescription drug ads Preventive monitoring United States Food and Drug Administration warning letters +
Compounding pharmacies dealt a blow in fight over end of semaglutide shortage on April 25, 2025 Compound enforcement Pharmacy facility semaglutide shortage United States Food and Drug Administration Wegovy +